Literature DB >> 24862303

Calculating the predicted retinal thickness from spectral domain and time domain optical coherence tomography - comparison of different methods.

Colin S Tan1, Kelvin Z Li, Tock Han Lim.   

Abstract

PURPOSE: To compare the accuracy of different methods of calculating predicted central retinal thickness values in order to allow comparison between results of spectral-domain optical coherence tomography (SD-OCT) and time-domain OCT (TD-OCT) devices.
METHODS: In a prospective cohort study, 100 consecutive healthy individuals without ocular disease underwent sequential scanning with SD-OCT (Spectralis OCT) and TD-OCT (Stratus OCT). A group of 60 eyes was used to generate the conversion equations, which were tested on the remaining 140 eyes. Four equations were used: 1. Mean difference between SD-OCT and TD-OCT; 2. Multiplying a ratio by the original retinal thickness; 3. Linear regression analysis using retinal thickness; and 4. Regression analysis using retinal thickness and spherical equivalent. All four methods were used to calculate predicted SD-OCT values from TD-OCT measurements, and vice versa.
RESULTS: For all four equations, the predicted SD-OCT central retinal thickness values were similar to the actual SD-OCT, with mean difference ranging from 0.78 to 1.01 μm, and intraclass correlation coefficients >0.88. Both regression equations and mean difference showed greater accuracy, with variation between calculated and actual retinal thickness values ≤5 μm in 60% of eyes. In contrast, the ratio method was less accurate, with 15.8 % of eyes showing differences >15 μm. Similar results were found for predicted TD-OCT values.
CONCLUSIONS: Several methods can be used to convert central retinal thickness values from SD-OCT to the predicted TD-OCT value, or vice versa, with high degrees of accuracy and reliability. These methods may allow comparison of OCT values from SD-OCT and TD-OCT devices in clinical trials and standard patient care.

Entities:  

Mesh:

Year:  2014        PMID: 24862303     DOI: 10.1007/s00417-014-2672-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  29 in total

1.  Retinal thickness and volume measurements in diabetic macular edema: a comparison of four optical coherence tomography systems.

Authors:  Jan Lammer; Christoph Scholda; Christian Prünte; Thomas Benesch; Ursula Schmidt-Erfurth; Matthias Bolz
Journal:  Retina       Date:  2011-01       Impact factor: 4.256

2.  Comparison of spectral- and time-domain optical coherence tomography for retinal thickness measurements in healthy and diseased eyes.

Authors:  Ian C Han; Glenn J Jaffe
Journal:  Am J Ophthalmol       Date:  2009-02-06       Impact factor: 5.258

3.  Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography.

Authors:  Christopher Kai-shun Leung; Carol Yim-lui Cheung; Robert N Weinreb; Gary Lee; Dusheng Lin; Chi Pui Pang; Dennis S C Lam
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04-30       Impact factor: 4.799

4.  Evaluation of time domain and spectral domain optical coherence tomography in the measurement of diabetic macular edema.

Authors:  Farzin Forooghian; Catherine Cukras; Catherine B Meyerle; Emily Y Chew; Wai T Wong
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-05-30       Impact factor: 4.799

5.  Comparison of manually corrected retinal thickness measurements from multiple spectral-domain optical coherence tomography instruments.

Authors:  Florian M Heussen; Yanling Ouyang; Emma C McDonnell; Ramsudha Narala; Humberto Ruiz-Garcia; Alexander C Walsh; SriniVas R Sadda
Journal:  Br J Ophthalmol       Date:  2011-07-06       Impact factor: 4.638

6.  Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments.

Authors:  Ute E K Wolf-Schnurrbusch; Lala Ceklic; Christian K Brinkmann; Milko E Iliev; Manuel Frey; Simon P Rothenbuehler; Volker Enzmann; Sebastian Wolf
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

7.  Comparison of retinal thickness in normal eyes using Stratus and Spectralis optical coherence tomography.

Authors:  Sandeep Grover; Ravi K Murthy; Vikram S Brar; Kakarla V Chalam
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-12-10       Impact factor: 4.799

8.  Macular thickness measurements in normal eyes with time-domain and Fourier-domain optical coherence tomography.

Authors:  Jingjing Huang; Xing Liu; Ziqiang Wu; Hui Xiao; Laurie Dustin; Srinivas Sadda
Journal:  Retina       Date:  2009 Jul-Aug       Impact factor: 4.256

9.  Macular thickness measurements in normal eyes using spectral domain optical coherence tomography.

Authors:  John E Legarreta; Giovanni Gregori; Omar S Punjabi; Robert W Knighton; Geeta A Lalwani; Carmen A Puliafito
Journal:  Ophthalmic Surg Lasers Imaging       Date:  2008 Jul-Aug

10.  Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial.

Authors:  Usha Chakravarthy; Simon P Harding; Chris A Rogers; Susan M Downes; Andrew J Lotery; Sarah Wordsworth; Barnaby C Reeves
Journal:  Ophthalmology       Date:  2012-05-11       Impact factor: 12.079

View more
  5 in total

1.  Letter to the editor: Forty-two-month outcome of intravitreal bevacizumab in myopic choroidal neovascularization.

Authors:  Milton C Chew; Colin S Tan
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2015-09-16       Impact factor: 3.117

2.  Comparability of retinal thickness measurements using different scanning protocols on spectral-domain optical coherence tomography.

Authors:  Milton C Chew; Louis W Lim; Eujin Tan; Colin S Tan
Journal:  Int Ophthalmol       Date:  2016-02-18       Impact factor: 2.031

Review 3.  The role of central reading centers--current practices and future directions.

Authors:  Colin S Tan; Srinivas R Sadda
Journal:  Indian J Ophthalmol       Date:  2015-05       Impact factor: 1.848

4.  Relationship between macular thickness measurement and signal strength using Stratus optical coherence tomography.

Authors:  Ori Segal; Yinon Shapira; Assaf Gershoni; Igor Vainer; Arie Y Nemet; Noa Geffen; Michael Mimouni
Journal:  Clin Ophthalmol       Date:  2016-11-11

5.  Predictors of persistent disease activity following anti-VEGF loading dose for nAMD patients in Singapore: the DIALS study.

Authors:  Colin S Tan; Louis W Lim; Wei Kiong Ngo; Pandiyan Pannirselvam; Clarence See; Wai Kitt Chee; Nakul Saxena
Journal:  BMC Ophthalmol       Date:  2020-08-06       Impact factor: 2.209

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.